AAIC 2018: BAN2401 yields promising results in Alzheimer’s disease treatment

Written by Olivia Stevenson, Future Science Group

Researchers from Eisai (Tokyo, Japan) and Biogen (MA, USA) have revealed the results of a recent study that suggests that patients given the highest doses of BAN2401 showed significantly slowed cognitive decline, as well as a reduction in amyloid plaques. This research could potentially bring about a promising new treatment for Alzheimer’s disease (AD). AD is becoming an increasingly widespread disease, with a huge emotional, as well as financial burden on the patients and their families. Because of this, uncovering a new and effective treatment for dementia patients is of high global priority. In this study, presented recently at the...

To view the full article, please register now for access

It's completely free